About: Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 17 April 2014

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2014 (ast) наукова стаття, опублікована у квітні 2014 (uk) scientific article published on 17 April 2014 (en) مقالة علمية نشرت في 17 أبريل 2014 (ar)
publication date	wds:Q37724201-9DFA6797-B4E8-4E70-986B-7011EE6A57C7
publication date	2014-04-17 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37724201-29545EFF-210F-4DC7-B55E-2191A0FE581D
language of work or name	English
cites work	wds:Q37724201-03209651-27A2-44B6-8F38-5D26BBEDAB2F wds:Q37724201-06D7FC6A-C2AA-472B-9952-024545769CC0 wds:Q37724201-0EA76193-FA77-401A-87E6-0631CC35EE64 wds:Q37724201-0FF03BB1-BE86-4212-8B1E-D0882D1355D6 wds:Q37724201-260ED570-736B-4993-AEEC-5560DB35AC7A wds:Q37724201-2FC674D4-6596-4C92-B902-28CB029DD661 wds:Q37724201-3D0E4F00-1DEE-4004-A04D-4D9260319ACD wds:Q37724201-440E651E-5B50-40C5-990B-547D8CDD4737 wds:Q37724201-447622D4-D3C9-460C-B995-7083C8959015 wds:Q37724201-523F0307-0C0C-4878-9254-D34EB78AA770 wds:Q37724201-5D7377B3-5C6E-49A8-9F0F-0A507F14E669 wds:Q37724201-672C4D29-CCB0-43C5-9CCB-4BAE0CB93778 wds:Q37724201-67551E3C-05A7-4D82-9471-4D2EC7B6A571 wds:Q37724201-685138CA-9FA0-475B-A14F-5DEB79FECFF4 wds:Q37724201-69E30C2C-ADB1-459A-B1F3-1D9655DBA993 wds:Q37724201-742F941E-2746-404F-BA9E-C64DB193A159 wds:Q37724201-796FEF1C-6951-45A4-A817-97DC203254A6 wds:Q37724201-81E19C53-C216-4678-8EBC-E9DA0A50758C wds:Q37724201-892B2FCB-06B6-4982-869A-0251B445C759 wds:Q37724201-99500EF6-91D3-4650-943D-2D5C1F7E9059 wds:Q37724201-D585BEAD-21A2-4FFB-9F31-79533E59A787 wds:Q37724201-EA29B868-2114-4A91-AD91-A931FA6B0E92 wds:Q37724201-EFA5AE7A-B699-4DA5-A5D7-4233AA4265DC wds:Q37724201-F5E9CC6A-E8E0-43CE-A669-DF411204A7B4 wds:Q37724201-F600EBAB-38BA-4280-8ECA-54F3CD0B2775 wds:Q37724201-F70544CC-58D2-4526-8EF9-6DAA6605A708 wds:Q37724201-F93B7C34-A48D-485D-8614-EDCAADC86612 wds:Q37724201-FFE03C3E-8F5B-4877-B388-236BE6A05B86
cites work	Cross-national epidemiology of DSM-IV major depressive episode The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder The size and burden of mental disorders and other disorders of the brain in Europe 2010. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study Agomelatine, the first melatonergic antidepressant: discovery, characterization and development Agomelatine: a narrative review The Course of Functional Decline in Older People with Persistently Elevated Depressive Symptoms: Longitudinal Findings from the Cardiovascular Health Study Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline Placebo-controlled trial of agomelatine in the treatment of major depressive disorder Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients. Accumulation of major depressive episodes over time in a prospective study indicates that retrospectively assessed lifetime prevalence estimates are too low Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice The economic cost of brain disorders in Europe Prospective evaluation of the effect of major depression on working status in a population sample. The antidepressant agomelatine in daily practice: results of the non-interventional study VIVALDI. The future of psychopharmacology of depression Lifetime prevalence estimates of major depression: an indirect estimation method and a quantification of recall bias. Lifetime risk of depression: restricted to a minority or waiting for most? Transition to mania during treatment of bipolar depression Rethinking depression and the actions of antidepressants: uncovering the links between the neural and behavioral elements Outcomes of 1014 naturalistically treated inpatients with major depressive episode. The incidence of first-onset depression in a population followed from the age of 70 to 85
author name string	wds:Q37724201-516F4CC5-CDBA-4B8A-A87D-02C56264EA64
author name string	Marina A Samushiya
rdfs:label	Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study (en) Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study (ast) Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study. (nl)
skos:prefLabel	Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study (en) Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study (ast) Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study. (nl)
name	Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study (en) Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study (ast) Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study. (nl)
author	wds:Q37724201-F00EC141-5AC7-45BB-97A7-C0D07303EF7D
author	S V Ivanov
title	wds:Q37724201-B4279064-B2CA-4010-97B9-A5CA8606334D
title	Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study (en)
page(s)	wds:Q37724201-941BEB69-0460-4122-9A2E-0250680D96A7
page(s)	631-639
instance of	wds:Q37724201-849E7AD4-8279-421B-81E6-88BF9FE84CE1
instance of	scholarly article
main subject	wds:Q37724201-8C5AE445-1A7F-4020-BCF5-C5C45641A418
main subject	multicenter clinical trial
PubMed ID	wds:Q37724201-D4C4C672-B4B0-43FA-B9E6-C741DA028321
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24790445

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software